Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

A good chunk of your paycheck goes to medical insurance. Know your options. Prudent action and planning maximize every dollar ...

New data show excellent quality-of-life outcomes and effective tumor control for both intensity-modulated radiation therapy ...

With Tuesday’s announcement, Eastern North Carolina adds to its reputation for large-scale pharmaceutical manufacturing, as ...

Three high-octane income stocks -- sporting an average yield of 6.23% -- have the necessary tools and intangibles to make ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...

Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual ...

The job cuts are part of a large cost-cutting programme at Pfizer and follow jobs it made to its Newbridge site last year.